5 Things to Know About Johnson & Johnson's New CEO
As he assumes his role as the company's Chief Executive Officer, we're sharing some facts about the respected business leader, who has deep roots at the company-and a commitment to helping improve health for people around the world.
In
Johnson & Johnson Earns a Spot on Fortune's 2021 Change the World List
As the world's most broadly based healthcare company,
To help introduce the new CEO, we have rounded up five things to know about Duato, including the fact that he is just the latest in a long line of family members with a passion for working in healthcare.
He is
Duato first joined
Over the past 33 years he has held leadership positions in nearly every division of
A hand holds a phone showing a doctor and numbers
How the Telehealth Trend Is Revolutionizing Medical Care As We Know It
Thanks in part to these rich and varied experiences at
So whenever he's advising a colleague or a team, Duato makes it a priority to seek diverse perspectives, which he understands are necessary for balanced decision-making and best representing the healthcare needs of people around the world.
2.He has a deep passion for the power and promise of technology.
Duato practicing the setup and connections for a Biosense Webster CARTO system in a Virtual Reality Simulation at the J&J Institute Hamburg in
In 2019, Duato served as interim Chief Information Officer-an experience that ignited his passion for leveraging intelligent automation and data science to advance and transform healthcare.
To that end, he does not think one has to be a scientist to learn from and use data to make informed decisions. He encourages employees across the organization to be tech bilingual-combining their fluency in science, biology or business with fluency in technology-to accelerate and simplify healthcare innovation.
Now, as CEO, Duato plans to ensure that technology is an integral component of all work being done across
An example of this is a smart memory diagnostic tool that the pharmaceutical team at Janssen is developing. It uses a tablet or smartphone to detect subtle changes in the brain that may indicate the onset of Alzheimer's disease. Using technology in this way could transform diagnosis and treatment of this devastating neurological disease.
3. Healthcare is woven into the fabric of his DNA.
Duato comes from a long line of family members who've nurtured a deep passion for the field of healthcare.
His mother was a nurse, his grandmother a pharmacist and his grandfather a pediatrician-and all of them taught Duato that the most important part of healthcare is care.
5 Impactful Ways Johnson & Johnson Supports Nurses and the Incredible Work They Do
'When your family works in healthcare, you witness the thrilling and tireless moments that healthcare demands,' Duato says. 'There are moments of great reward and also moments of great sadness. This is why I believe society has a responsibility to care for those who care for us-this includes the mental and emotional well-being of frontline healthcare workers.'
Quote icon (top)
In 2017 Duato was named an
Quote icon (bottom)
4. Mentorship is another form of care he holds close to his heart.
Throughout his career, Duato has credited mentors for his development, especially those who helped ease his transition when he moved to the
Since then, he has done his part to pay it forward, helping others unlock their potential, gain confidence and pursue new career opportunities.
For almost a decade, he also served as the executive sponsor of the
His mentorship efforts were recognized in 2017, when Duato was named an
'Joaquin Duato has a phenomenal track record of developing and promoting female leaders, and the
As CEO, he is committed to creating an even more inclusive and empowered work environment at
5.Duato's vision for the company is rooted in long-term thinking.
Starting in 2009, Duato worked to transform the pharmaceutical business for growth over the long term. He did this by refocusing the business on its strengths, with the opportunity to create transformational medical innovations to help patients and communities in greatest need.
How
In partnership with the Chief Scientific Officer, Duato prioritized the business strategy and R&D efforts around six areas of focus: cardiovascular and metabolism, immunology, infectious diseases and vaccines, neuroscience, oncology and pulmonary hypertension.
Over time, these decisions proved powerful, with more than 20 new medicines approved since then, which contributed to five consecutive years of growth, including two years as the fastest-growing pharmaceutical company in the world.
Looking back, Duato sees significant parallels to his new chapter as CEO.
'We created a clear set of steps to reinvent the business and were guided by our
Want to learn more about
(C) 2022 Electronic News Publishing, source